atorvastatin has been researched along with Airflow Obstruction, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; He, Y; Huang, L; Li, Y; Wang, S | 1 |
| Chang, R; Cheng, N; Lu, Y; Teng, Y; Xu, X; Yao, J | 1 |
| Bierla, J; Boros, P; Chyczewska, E; Duszewska, AM; Lisowska, A; Lisowski, P; MacNee, W; Milewski, R; Minarowski, L; Mroz, RM; Musial, WJ; Sobkowicz, B; Trzeciak, PZ; Tycinska, A | 1 |
| DeFilippis, A; Eberlein, M; Girgis, RE; Iacono, A; Jones, S; Lechtzin, N; Reed, RM | 1 |
| Chan, WC; Hopkins, R; Jackson, G; Lawes, CM; Marshall, R; Thornley, S; Young, R | 1 |
| Pearson, M | 1 |
1 review(s) available for atorvastatin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Effectiveness of long-term using statins in COPD - a network meta-analysis.
Topics: Atorvastatin; Drug Administration Schedule; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Network Meta-Analysis; Pulmonary Disease, Chronic Obstructive; Simvastatin; Time Factors; Treatment Outcome | 2019 |
1 trial(s) available for atorvastatin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study.
Topics: Aged; Anti-Infective Agents; Atorvastatin; Biopsy; Female; Gene Expression Profiling; Gene Expression Regulation; Genetic Markers; Genome-Wide Association Study; Humans; Immunohistochemistry; Inflammation Mediators; Lung; Lymphocyte Activation; Male; Middle Aged; Pilot Projects; Poland; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Respiratory Function Tests; Severity of Illness Index; Single-Blind Method; Time Factors; Treatment Outcome | 2015 |
4 other study(ies) available for atorvastatin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Effects of atorvastatin in suppressing pulmonary vascular remodeling in rats with chronic obstructive pulmonary disease.
Topics: Animals; Atorvastatin; Female; Inflammation; Lung; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Remodeling | 2023 |
Statin therapy is associated with decreased pulmonary vascular pressures in severe COPD.
Topics: Aged; Atorvastatin; Cross-Sectional Studies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Pulmonary Wedge Pressure; Pyrroles; Regression Analysis; Simvastatin | 2011 |
Statin use in COPD patients is associated with a reduction in mortality: a national cohort study.
Topics: Aged; Atorvastatin; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medical Record Linkage; Middle Aged; New Zealand; Pulmonary Disease, Chronic Obstructive; Pyrroles; Simvastatin; Treatment Outcome | 2012 |
Statins for COPD: a challenge to conventional beliefs?
Topics: Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pulmonary Disease, Chronic Obstructive; Pyrroles; Simvastatin | 2012 |